Gil chemogenetically inhibits the TRN while optogenetically stimulating novel afferents: a first-ever all-in-one experiment in our lab!
NEWS
2018, August 27th - by Anita Luthi
All in one: Gil makes opto- and chemogenetics work within one experiment
